Prestige Consumer Healthcare Inc. (PBH) Income Statement
PBH FY2026 at a glance
Fiscal year ended March 31, 2026 · U.S. dollarsPBH revenue and net income
Where PBH's revenue goes
FY2026Each bar shows an amount and its share of revenue. PBH kept 17.5% of revenue as net income.
PBH profit margins
PBH growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −4.3% | −1.2% | +2.9% | +3.0% |
| Gross profit | −9.4% | −2.8% | +1.0% | +2.1% |
| Operating income | −8.1% | — | +0.8% | +1.7% |
| Net income | −11.3% | — | +2.9% | +6.7% |
| EPS (diluted) | −7.7% | −0.3% | +5.2% | +6.8% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
PBH quarterly EPS vs estimates
Prestige Consumer Healthcare beat the analyst EPS estimate in 4 of the last 8 quarters. Next report: November 5, 2026 (estimate $1.06).
PBH income statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943.4M | $963.0M | $975.8M | $1.04B | $882.1M |
| Cost of revenue | $514.1M | $503.3M | $500.9M | $502.4M | $466.2M | $395.9M | $410.8M | $420.2M | $464.7M | $381.8M |
| Gross profit | $574.6M | $634.5M | $624.4M | $625.3M | $620.6M | $547.5M | $552.2M | $555.6M | $576.5M | $500.3M |
| Research & development | — | — | — | — | — | — | — | — | $0 | $0 |
| Sales, general & admin | $265.2M | $263.9M | $259.5M | $252.4M | $264.8M | $223.7M | $236.3M | $232.8M | $332.2M | $217.5M |
| Total operating expenses | $265.2M | $297.7M | $282.0M | $647.7M | $290.7M | $250.1M | $261.1M | $259.9M | $360.6M | $242.9M |
| Operating income | $309.4M | $336.8M | $342.4M | −$22.4M | $329.9M | $297.4M | $291.2M | $67.5M | $215.9M | $205.6M |
| Interest income | — | $47.6M | $67.2M | $69.2M | $64.3M | $82.3M | $342,000 | $217,000 | $388,000 | $203,000 |
| Interest expense | $42.3M | $47.6M | $67.2M | $69.2M | $64.3M | $82.3M | $96.6M | $105.3M | $106.3M | $93.5M |
| Income before taxes | $257.5M | $284.2M | $276.0M | −$93.9M | $262.5M | $204.1M | $191.2M | −$38.1M | $107.1M | $110.8M |
| Income taxes | $67.2M | $69.6M | $66.7M | −$11.6M | $57.1M | $39.4M | $48.9M | −$2.3M | −$232.5M | $41.5M |
| Net income | $190.3M | $214.6M | $209.3M | −$82.3M | $205.4M | $164.7M | $142.3M | −$35.8M | $339.6M | $69.4M |
| EBITDA | $331.1M | $362.0M | $373.9M | $7.9M | $358.8M | $316.6M | $316.7M | $98.8M | $355.7M | $304.5M |
| EPS (diluted) | $4.18 | $4.53 | $4.21 | $4.22 | $4.06 | $3.24 | $2.96 | $2.78 | $2.59 | $2.37 |
| Gross margin | 52.8% | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% |
| Operating margin | 28.4% | 29.6% | 30.4% | −2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% |
| Net margin | 17.5% | 18.9% | 18.6% | −7.3% | 18.9% | 17.5% | 14.8% | −3.7% | 32.6% | 7.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $265.7M | $281.6M | $283.4M | $274.1M | $249.5M | $296.8M | $290.3M | $283.5M | $267.1M | $277.0M | $282.7M | $286.3M |
| Cost of revenue | $129.5M | $140.8M | $126.1M | $120.0M | $114.4M | $121.0M | $129.3M | $126.2M | $121.1M | $125.2M | $124.8M | $126.3M |
| Gross profit | $136.2M | $140.9M | $157.4M | $154.1M | $135.1M | $175.7M | $161.0M | $157.4M | $146.0M | $151.8M | $157.9M | $160.0M |
| Sales, general & admin | $78.0M | $65.4M | $69.7M | $66.7M | $63.4M | $64.1M | $64.1M | $67.5M | $68.3M | $64.0M | $65.5M | $66.1M |
| Total operating expenses | $83.7M | $65.4M | $74.9M | $74.4M | $63.4M | $87.3M | $69.1M | $73.0M | $74.0M | $69.7M | $71.1M | $71.8M |
| Operating income | $52.5M | $75.5M | $82.5M | $79.7M | $71.8M | $88.4M | $92.0M | $84.3M | $72.0M | $82.2M | $86.8M | $88.2M |
| Interest income | — | — | $10.7M | $10.0M | $10.2M | $10.8M | $11.5M | $12.3M | — | — | — | $17.6M |
| Interest expense | $13.9M | $11.4M | $10.7M | $10.0M | $10.2M | $10.8M | $11.5M | $12.3M | $13.1M | $15.3M | $16.6M | $17.6M |
| Income before taxes | $38.5M | $64.8M | $61.8M | $69.1M | $61.8M | $74.0M | $80.2M | $71.7M | $58.4M | $67.3M | $69.6M | $70.4M |
| Income taxes | $9.4M | $10.8M | $15.1M | $26.9M | $14.3M | $23.8M | $19.1M | $17.3M | $9.3M | $17.9M | $16.5M | $16.9M |
| Net income | $29.2M | $53.9M | $46.7M | $42.2M | $47.5M | $50.1M | $61.0M | $54.4M | $49.1M | $49.5M | $53.0M | $53.6M |
| EBITDA | $61.2M | $84.6M | $80.1M | $86.8M | $79.6M | $92.0M | $98.5M | $91.9M | $79.7M | $90.4M | $93.8M | $95.7M |
| EPS (diluted) | $0.98 | $1.23 | $1.14 | $0.86 | $0.95 | $1.32 | $1.22 | $1.09 | $0.90 | $1.02 | $1.06 | $1.07 |
| Gross margin | 51.3% | 50.0% | 55.5% | 56.2% | 54.2% | 59.2% | 55.5% | 55.5% | 54.7% | 54.8% | 55.9% | 55.9% |
| Operating margin | 19.8% | 26.8% | 29.1% | 29.1% | 28.8% | 29.8% | 31.7% | 29.7% | 27.0% | 29.7% | 30.7% | 30.8% |
| Net margin | 11.0% | 19.1% | 16.5% | 15.4% | 19.0% | 16.9% | 21.0% | 19.2% | 18.4% | 17.9% | 18.8% | 18.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in PBH's financial statements (latest annual report filed May 14, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
PBH financial results
In fiscal year 2026 (ended March 31, 2026), Prestige Consumer Healthcare reported revenue of $1.1 billion, down 4.3% from the year before. It had net income of $190.3 million (down 11.3%), a net profit margin of 17.5%. Diluted earnings per share came to $4.18. Over five years revenue grew at an average rate of 2.9% a year.
See the PBH stock overview for the latest quote and news, or the PBH chart for price history and technical indicators.
PBH income statement FAQ
What is Prestige Consumer Healthcare's annual revenue?
Prestige Consumer Healthcare reported total revenue of $1.1 billion for fiscal year 2026, which ended on March 31, 2026. That was down 4.3% from $1.1 billion the previous year.
Is Prestige Consumer Healthcare profitable?
Yes. Prestige Consumer Healthcare reported net income of $190.3 million in fiscal 2026, a net profit margin of 17.5%; its operating margin was 28.4%.
What is Prestige Consumer Healthcare's gross margin?
Prestige Consumer Healthcare's gross margin was 52.8% in fiscal 2026: for every $100 of revenue, Prestige Consumer Healthcare kept $53 after the direct cost of its products and services.
How fast is Prestige Consumer Healthcare growing?
Revenue grew 2.9% a year on average over the last five fiscal years, from $943.4 million to $1.1 billion.
What are Prestige Consumer Healthcare's earnings per share?
Prestige Consumer Healthcare earned $4.18 per diluted share in fiscal 2026, compared with $4.53 a year earlier.
When will Prestige Consumer Healthcare report its next earnings?
Prestige Consumer Healthcare is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.
When does Prestige Consumer Healthcare's fiscal year end?
Prestige Consumer Healthcare's fiscal year ends in March. The latest annual report covers the year ended March 31, 2026 and was filed on May 14, 2026.